Brixton Biosciences’ $33 Million Series B Financing Round

Leila Ahmed
Tagged:

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brixton Biosciences in the transaction.Brixton Biosciences, a clinical stage life sciences company, announced it has raised $33 million…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now